Barely Significant
← all phrases

“borderline significant”

11,410 sentences · 11,410 papers · 14,072 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

The results of this study are borderline significant and suggest a possible role of iNOS (CCTTT) n polymorphism in the risk of asbestosis; however, further studies are needed. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes 1.
8 ). Multivariate logistic regression model Of the 16 tested variables (Table 3 ), only an urban setting ( p value < 0.001, OR = 67.646) and density of dogs ( p value = 0.037, OR = 1.944) and cattle ( p value = 0.007, OR = 1.203) were significant explanatory variables whilst irrigated farms were borderline significant and there were trends for dry farmlands and humidity.
The statistically borderline significant, but weak positive, correlation of TB counts in biopsy and in subsequent post-NAT resection specimens (Fig. 3 ) suggests that TB may not only be a morphological feature of tumor growth but also related to the intrinsic aggressive biological characteristics of the tumor.
However, for AML, there was a statistically significant or borderline significant reduced risk associated with any use of non-aspirin NSAIDs (OR=0.60, CI: 0.37–0.97) and acetaminophen (OR=0.66, CI: 0.43–1.01), respectively, but not with aspirin (OR=0.55, CI: 0.24–1.26); regular use of each analgesic did not reflect further reduction in risk.
With the exception of a borderline significant association between a lower baseline HAMD-17 total score and remission (OR=0.87, 95%CI=0.75-1.00), none of the other factors considered (e.g., age, gender, marital status, age of onset, duration of illness, and number of episodes) were significantly associated with the effectiveness or remission rate after 12 weeks of treatment with duloxetine. 3.3 Adverse effects and use of adjunctive medication As shown in Table 5, about half of the participants in both groups reported one or more adverse effects during the 12 weeks of treatment.